{"id":"NCT03205371","sponsor":"Sanofi Pasteur, a Sanofi Company","briefTitle":"Immunogenicity and Safety of a Meningococcal Conjugate Vaccine Given Concomitantly With Other Vaccines in Toddlers","officialTitle":"Immunogenicity and Safety of an Investigational Quadrivalent Meningococcal Conjugate Vaccine Administered Concomitantly With Other Pediatric Vaccines in Healthy Toddlers","status":"COMPLETED","phase":"PHASE3","dates":{"start":"2016-11-07","primaryCompletion":"2018-07-19","completion":"2018-07-19","firstPosted":"2017-07-02","resultsPosted":"2020-06-09","lastUpdate":"2022-04-05"},"enrollment":1183,"design":{"allocation":"RANDOMIZED","model":"PARALLEL","masking":"SINGLE","primaryPurpose":"PREVENTION"},"conditions":["Meningitis, Meningococcal"],"interventions":[{"type":"BIOLOGICAL","name":"MenACYW conjugate vaccine","otherNames":[]},{"type":"BIOLOGICAL","name":"MMR","otherNames":[]},{"type":"BIOLOGICAL","name":"Varicella","otherNames":[]},{"type":"BIOLOGICAL","name":"DTaP-IPV-HB-Hib","otherNames":[]},{"type":"BIOLOGICAL","name":"PCV13","otherNames":[]}],"arms":[{"label":"South Korea(Group1):MenACYW Conjugate + MMR+ Varicella Vaccine","type":"EXPERIMENTAL"},{"label":"South Korea (Group 2): MenACYW Conjugate Vaccine","type":"EXPERIMENTAL"},{"label":"South Korea (Group 3): MMR + Varicella Vaccine","type":"ACTIVE_COMPARATOR"},{"label":"Thailand (Group 10):MenACYW Conjugate +MMR+Varicella Vaccine","type":"EXPERIMENTAL"},{"label":"Thailand (Group 11):MenACYW Conjugate Vaccine","type":"EXPERIMENTAL"},{"label":"Thailand (Group 12): MMR + Varicella Vaccine","type":"ACTIVE_COMPARATOR"},{"label":"Mexico (Group 4): MenACYW Conjugate + DTaP-IPV-HB-Hib Vaccine","type":"EXPERIMENTAL"},{"label":"Mexico (Group 5): MenACYW Conjugate Vaccine","type":"EXPERIMENTAL"},{"label":"Mexico (Group 6): DTaP-IPV-HB-Hib Vaccine","type":"ACTIVE_COMPARATOR"},{"label":"Russian Federation (Group7): MenACYW Conjugate + PCV13 Vaccine","type":"EXPERIMENTAL"},{"label":"Russian Federation (Group 8): MenACYW Conjugate Vaccine","type":"EXPERIMENTAL"},{"label":"Russian Federation (Group 9): PCV13 Vaccine","type":"ACTIVE_COMPARATOR"}],"summary":"This Phase III, open-label, randomized, parallel-group, active-controlled, multicenter study was conducted to assess the immunogenicity and safety of a single dose of Meningococcal Polysaccharide (Serogroups A, C, Y and W) Tetanus Toxoid (MenACYW) Conjugate vaccine when administered alone and in combination with other pediatric vaccines in healthy toddlers in South Korea, Thailand, the Russian Federation, and Mexico.\n\nPrimary Objective:\n\n* To describe the immunogenicity profile of MenACYW Conjugate vaccine administered alone or concomitantly with licensed pediatric vaccine(s) (measles-mumps-rubella vaccine \\[MMR\\] + Varicella, diphtheria, tetanus, acellular pertussis, hepatitis B, poliomyelitis, and Haemophilus influenzae type-b Conjugate vaccine \\[DTaP-IPV-HB-Hib\\], or pneumococcal Conjugate vaccine \\[PCV13\\]).\n\nSecondary Objective:\n\n* To describe the immunogenicity profile of licensed pediatric vaccine(s) (MMR + Varicella, DTaP-IPV-HB-Hib, or PCV13) when administered alone or concomitantly with MenACYW Conjugate vaccine.","primaryOutcome":{"measure":"Geometric Mean Titers of Meningococcal Serogroups A, C, Y, and W Antibodies Following Injection With MenACYW Conjugate Vaccine Administered Alone or Concomitantly With Other Pediatric Vaccines: Groups 1, 2, 4, 5, 7, 8, 10, and 11","timeFrame":"Day 0 and Day 30 post-vaccination","effectByArm":[{"arm":"Groups 1and10: MenACYW Conjugate Vaccine+MMR+Varicella Vaccine","deltaMin":5.2,"sd":null},{"arm":"Groups 2 and 11: MenACYW Conjugate Vaccine","deltaMin":6.1,"sd":null},{"arm":"Mexico (Group 4): MenACYW Conjugate + DTaP-IPV-HB-Hib Vaccine","deltaMin":5.35,"sd":null},{"arm":"Mexico (Group 5): MenACYW Conjugate Vaccine","deltaMin":5.49,"sd":null},{"arm":"Russian Federation (Group 7): MenACYW Conjugate +PCV13 Vaccine","deltaMin":5.99,"sd":null},{"arm":"Russian Federation (Group 8): MenACYW Conjugate Vaccine","deltaMin":8.54,"sd":null}],"pValues":[]},"eligibility":{"minAge":"12 Months","sex":"ALL","healthyVolunteers":true,"inclusionCount":13,"exclusionCount":20},"locations":{"siteCount":37,"countries":["Mexico","Russia","South Korea","Thailand"]},"refs":{"pmids":["33814028"],"seeAlso":["http://www.sanofipasteur.com"]},"adverseEventsSummary":{"seriousAny":{"events":6,"n":103},"commonTop":["Injection Site Pain","Injection Site Erythema","Irritability","Decreased Appetite","Injection Site Swelling"]}}